MedTrace Logo

Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)

NCT01952600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2016-09-20

Study results available
· View outcomes & findings →

Summary

The EPOCH-RRT study seeks to fill knowledge gaps by gaining more understanding of chronic kidney disease (CKD) patients' priorities; assessing the comparative benefits of hemodialysis (HD) versus peritoneal dialysis (PD), with respect to these priorities; and providing tailored information to assist patients with identifying the best dialysis modality fit for their own unique circumstances and perspectives.

The outcomes most relevant to patients ("patient-centered") extend beyond those traditionally assessed in clinical research, with the relative importance varying across patient groups. A tailored decision aid based on these findings can improve patient decision-making processes regarding choice of dialysis modality.

Conditions

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • Henry Ford Health System

    collaborator OTHER

  • National Kidney Foundation, United States

    collaborator OTHER

  • American Association of Kidney Patients

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Arbor Research Collaborative for Health

    lead OTHER

Principal Investigators

  • Francesca Tentori, MD, MS · Arbor Research Collaborative for Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01952600 on ClinicalTrials.gov